-
N.
Naka,
M.
Kawahara,
K.
Okishio,
S.
Hosoe,
M.
Ogawara,
S.
Atagi,
Y.
Takemoto,
K.
Ueno,
T.
Kawaguchi,
T.
Tsuchiyama,
K.
Furuse
(2002)
Phase II study of weekly irinotecan and carboplatin for refractory or relapsed small-cell lung cancer.
Lung cancer, 37 3
-
Radhey
Gupta,
Rajni
Gupta,
Barry
Eng,
Richard
Lock,
Warren
Ross,
Robert
Hertzberg,
M.
Caranfa,
Randall
Johnson
(1988)
Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase I.
Cancer research, 48 22
-
R.
Kim,
N.
Hirabayashi,
M.
Nishiyama,
K.
Jinushi,
T.
Toge,
K.
Okada
(1992)
Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude mice
International Journal of Cancer, 50
-
B.
Grønberg,
R.
Bremnes,
U.
Aasebø,
P.
Brunsvig,
O.
Fløtten,
T.
Amundsen,
C.
Plessen,
Mari
Wang,
S.
Sundstrøm
(2009)
A prospective phase II study: high-dose pemetrexed as second-line chemotherapy in small-cell lung cancer.
Lung cancer, 63 1
-
Ting-chao
Chou,
P.
Talalay
(1977)
A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems.
The Journal of biological chemistry, 252 18
-
A.
Ardizzoni,
C.
Manegold,
C.
Debruyne,
R.
Gaafar,
E.
Buchholz,
E.
Smit,
P.
Lianes,
Guul
Velde,
L.
Bosquée,
C.
Legrand,
C.
Neumaier,
Kathrine
King
(2003)
European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research, 9 1
-
T.
Shibayama,
K.
Hotta,
N.
Takigawa,
A.
Tada,
H.
Ueoka,
S.
Harita,
K.
Kiura,
M.
Tabata,
Y.
Segawa,
N.
Nogami,
S.
Kuyama,
T.
Shinkai,
M.
Tanimoto
(2006)
A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancer.
Lung cancer, 53 2
-
S.
Kakolyris,
D.
Mavroudis,
N.
Tsavaris,
J.
Souglakos,
P.
Tsiafaki,
K.
Kalbakis,
S.
Agelaki,
N.
Androulakis,
V.
Georgoulias
(2001)
Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology, 12 2
-
Y.
Matsunaga,
A.
Hamada,
I.
Okamoto,
J.
Sasaki,
E.
Moriyama,
H.
Kishi,
M.
Matsumoto,
Asumi
Hira,
Hiroshi
Watanabe,
H.
Saito
(2006)
Pharmacokinetics of Amrubicin and Its Active Metabolite Amrubicinol in Lung Cancer Patients
Therapeutic Drug Monitoring, 28
-
F.
Oshita,
H.
Saito,
Kouzo
Yamada
(2008)
Dose Escalation Study of Amrubicin in Combination with Fixed-Dose Irinotecan in Patients with Extensive Small-Cell Lung Cancer
Oncology, 74
-
N.
Masuda,
M.
Fukuoka,
Y.
Kusunoki,
K.
Matsui,
N.
Takifuji,
S.
Kudoh,
S.
Negoro,
M.
Nishioka,
K.
Nakagawa,
M.
Takada
(1992)
CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 10 8
-
EF
Smit,
E.
Fokkema,
B.
Biesma,
Hjm
Groen,
W.
Snoek,
Pe
Postmus
(1998)
A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer.
British Journal of Cancer, 77
-
G.
Steel,
M.
Peckham
(1979)
Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity.
International journal of radiation oncology, biology, physics, 5 1
-
M.
Hanada,
T.
Noguchi,
T.
Yamaoka
(2007)
Amrubicin, a novel 9‐aminoanthracycline, enhances the antitumor activity of chemotherapeutic agents against human cancer cells in vitro and in vivo
Cancer Science, 98
-
K.
Hotta,
N.
Takigawa,
K.
Kiura,
M.
Tabata,
S.
Umemura,
Atsuko
Ogino,
A.
Uchida,
A.
Bessho,
Y.
Segawa,
T.
Shinkai,
N.
Nogami,
S.
Harita,
N.
Okimoto,
H.
Ueoka,
M.
Tanimoto
(2005)
Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancer.
Anticancer research, 25 3c
-
M.
Hanada,
Satoko
Mizuno,
Akihisa
Fukushima,
Yoshikazu
Saito,
T.
Noguchi,
T.
Yamaoka
(1998)
A New Antitumor Agent Amrubicin Induces Cell Growth Inhibition by Stabilizing Topoisomerase II‐DNA Complex
Japanese Journal of Cancer Research : Gann, 89
-
S.
Yamauchi,
S.
Kudoh,
Tatsuo
Kimura,
K.
Hirata,
J.
Yoshikawa
(2002)
Additive effects of amrubicin with cisplatin on human lung cancer cell lines.
Osaka city medical journal, 48 1
-
Sayaka
Onoda,
N.
Masuda,
T.
Seto,
K.
Eguchi,
Y.
Takiguchi,
H.
Isobe,
H.
Okamoto,
T.
Ogura,
A.
Yokoyama,
N.
Seki,
Y.
Asaka-Amano,
M.
Harada,
A.
Tagawa,
H.
Kunikane,
M.
Yokoba,
K.
Uematsu,
T.
Kuriyama,
Y.
Kuroiwa,
Koshiro
Watanabe
(2006)
Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 34
-
N.
Takigawa,
M.
Takeyama,
T.
Shibayama,
A.
Tada,
N.
Kawata,
C.
Okada,
K.
Aoe,
T.
Kozuki,
K.
Hotta,
M.
Tabata,
K.
Kiura,
H.
Ueoka,
M.
Tanimoto,
Kiyoshi
Takahashi
(2006)
The combination effect of amrubicin with cisplatin or irinotecan for small-cell lung cancer cells.
Oncology reports, 15 4
-
F.
Shepherd,
W.
Evans,
R.
Maccormick,
R.
Feld,
J.
Yau
(1987)
Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer.
Cancer treatment reports, 71 10
-
Tadashi
Suzuki,
S.
Minamide,
T.
Iwasaki,
Hirohisa
Yamamoto,
H.
Kanda
(2004)
Cardiotoxicity of a new anthracycline derivative (SM-5887) following intravenous administration to rabbits: Comparative study with doxorubicin
Investigational New Drugs, 15
-
T.
Hoang,
KyungMann
Kim,
A.
Jaslowski,
Paul
Koch,
P.
Beatty,
J.
McGovern,
Maria
Quisumbing,
G.
Shapiro,
R.
Witte,
J.
Schiller
(2003)
Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer.
Lung cancer, 42 1
-
Noriyuki
Masuda,
K.
Matsui,
S.
Negoro,
N.
Takifuji,
K.
Takeda,
T.
Yana,
Masashi
Kobayashi,
T.
Hirashima,
Yoko
Kusunoki,
S.
Ushijima,
Ichiro
Kawase,
T.
Tada,
Hirochiyo
Sawaguchi,
Masahiro
Fukuoka
(1998)
Combination of irinotecan and etoposide for treatment of refractory or relapsed small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 16 10
-
T.
Yamaoka,
M.
Hanada,
S.
Ichii,
S.
Morisada,
T.
Noguchi,
Y.
Yanagi
(1998)
Cytotoxicity of Amrubicin, a Novel 9‐Aminoanthracycline, and Its Active Metabolite Amrubicinol on Human Tumor Cells
Japanese Journal of Cancer Research : Gann, 89
-
D.
Johnson,
F.
Greco,
J.
Strupp,
K.
Hande,
J.
Hainsworth
(1990)
Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 8 10
-
R.
Weiss,
G.
Sarosy,
K.
Clagett-Carr,
M.
Russo,
B.
Leyland-Jones
(2004)
Anthracycline analogs The past, present, and future
Cancer Chemotherapy and Pharmacology, 18
-
M.
Ando,
K.
Kobayashi,
A.
Yoshimura,
F.
Kurimoto,
M.
Seike,
M.
Nara,
Gaku
Moriyama,
H.
Mizutani,
S.
Hibino,
A.
Gemma,
T.
Okano,
M.
Shibuya,
S.
Kudoh
(2004)
Weekly administration of irinotecan (CPT-11) plus cisplatin for refractory or relapsed small cell lung cancer.
Lung cancer, 44 1
-
S.
Kudoh,
N.
Yoshimura,
Tatsuo
Kimura,
S.
Mitsuoka,
Kazuto
Hirata
(2006)
A phase II trial of amrubicin (AMR) for recurrent or refractory small cell lung cancer (SCLC).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 18_suppl
-
T.
Mok,
H.
Wong,
B.
Zee,
K.
Yu,
T.
Leung,
T.
Lee,
A.
Yim,
A.
Chan,
W.
Yeo,
K.
Chak,
P.
Johnson
(2002)
A Phase I–II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma
Cancer, 95
-
Caio
Rocha-Lima,
James
Herndon,
Me
Lee,
J.
Atkins,
A.
Mauer,
E.
Vokes,
Green
(2006)
Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902.
Annals of oncology : official journal of the European Society for Medical Oncology, 18 2
-
J.
Jassem,
H.
Karnicka-Młodkowska,
C.
Pottelsberghe,
M.
Glabbeke,
M.
Noseda,
A.
Ardizzoni,
F.
Gozzelino,
A.
Planting,
N.
Zandwijk
(1993)
Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patients. EORTC Lung Cancer Cooperative Group.
European journal of cancer, 29A 12
-
K.
Kaira,
N.
Sunaga,
Y.
Tomizawa,
N.
Yanagitani,
K.
Shimizu,
H.
Imai,
M.
Utsugi,
Yasuki
Iwasaki,
H.
Iijima,
Hiroaki
Tsurumaki,
A.
Yoshii,
N.
Fueki,
T.
Hisada,
T.
Ishizuka,
R.
Saito,
M.
Mori
(2010)
A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer.
Lung cancer, 69 1
-
T.
Sugiura,
Y.
Ariyoshi,
S.
Negoro,
S.
Nakamura,
H.
Ikegami,
M.
Takada,
T.
Yana,
M.
Fukuoka
(2005)
Phase I/II study of amrubicin, a novel 9-aminoanthracycline, in patients with advanced non-small-cell lung cancer
Investigational New Drugs, 23
-
S.
Morisada,
Y.
Yanagi,
T.
Noguchi,
Y.
Kashiwazaki,
M.
Fukui
(1989)
Antitumor Activities of a Novel 9‐Aminoanthracycline (SM‐5887) against Mouse Experimental Tumors and Human Tumor Xenografts
Japanese Journal of Cancer Research : Gann, 80
-
D.
Ettinger,
R.
Jotte,
P.
Lorigan,
Vicram
Gupta,
L.
Garbo,
C.
Alemany,
P.
Conkling,
D.
Spigel,
A.
Dudek,
C.
Shah,
R.
Salgia,
R.
Mcnally,
M.
Renschler,
J.
Oliver
(2010)
Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 15
-
S
Kaufmann
(1991)
Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.
Cancer research, 51 4
-
Jiro
Ikeda,
R.
Maruyama,
T.
Okamoto,
F.
Shoji,
H.
Wataya,
Y.
Ichinose
(2006)
Phase I study of amrubicin hydrochloride and cisplatin in patients previously treated for advanced non-small cell lung cancer.
Japanese journal of clinical oncology, 36 1
-
Clinical Medicine Insights: Oncology
-
T.
Noguchi,
S.
Ichii,
S.
Morisada,
T.
Yamaoka,
Y.
Yanagi
(1998)
In vivo Efficacy and Tumor‐selective Metabolism of Amrubicin to Its Active Metabolite
Japanese Journal of Cancer Research : Gann, 89
-
T.
Noguchi,
S.
Ichii,
S.
Morisada,
T.
Yamaoka,
Y.
Yanagi
(1998)
Tumor‐selective Distribution of an Active Metabolite of the 9‐Aminoanthracycline Amrubicin
Japanese Journal of Cancer Research : Gann, 89
-
(1985)
Annu Rev Biochem
-
T.
Yana,
S.
Negoro,
M.
Takada,
S.
Yokota,
Y.
Takada,
T.
Sugiura,
Hidehiko
Yamamoto,
T.
Sawa,
M.
Kawahara,
N.
Katakami,
Y.
Ariyoshi,
M.
Fukuoka
(2007)
Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study
Investigational New Drugs, 25
-
N.
Nogami,
K.
Kiura,
N.
Takigawa,
S.
Harita,
K.
Chikamori,
T.
Shibayama,
M.
Tabata,
K.
Hotta,
T.
Shinkai,
M.
Tanimoto
(2010)
A phase II trial of combination chemotherapy with topotecan and amrubicin in small cell lung cancer (SCLC).
Journal of Clinical Oncology, 28
-
R.
Jotte,
P.
Conkling,
C.
Reynolds,
A.
Allen,
J.
Oliver
(2007)
A randomized phase II trial of amrubicin (AMR) vs. topotecan as second-line treatment in extensive-disease small-cell lung cancer (SCLC) sensitive to platinum-based first-line chemotherapy
Journal of Clinical Oncology, 26
-
J.
Eckardt,
D.
Bentsion,
O.
Lipatov,
I.
Polyakov,
F.
Mackintosh,
D.
Karlin,
G.
Baker,
H.
Breitz
(2009)
Phase II study of picoplatin as second-line therapy for patients with small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 12
-
S.
Igawa,
N.
Yamamoto,
S.
Ueda,
A.
Ono,
Yukiko
Nakamura,
A.
Tsuya,
H.
Murakami,
M.
Endo,
Toshiaki
Takahashi
(2007)
Evaluation of the Recommended Dose and Efficacy of Amrubicin as Second- and Third-Line Chemotherapy for Small Cell Lung Cancer
Journal of Thoracic Oncology, 2
-
E.
Faylona,
P.
Loehrer,
R.
Ansari,
A.
Sandler,
R.
Gonin,
L.
Einhorn
(1995)
Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier Oncology Group Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 13 5
-
(2010)
J Clin Oncol
-
E.
Quoix,
J.
Breton,
R.
Gervais,
Jonathan
Wilson,
F.
Schramel,
F.
Cardenal,
G.
Ross,
A.
Preston,
M.
Lymboura,
K.
Mattson
(2005)
A randomised phase II study of the efficacy and safety of intravenous topotecan in combination with either cisplatin or etoposide in patients with untreated extensive disease small-cell lung cancer.
Lung cancer, 49 2
-
Y.
Ohe,
S.
Negoro,
K.
Matsui,
K.
Nakagawa,
T.
Sugiura,
Y.
Takada,
Y.
Nishiwaki,
S.
Yokota,
M.
Kawahara,
N.
Saijo,
M.
Fukuoka,
Y.
Ariyoshi
(2005)
Phase I-II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology, 16 3
-
S.
Jalal,
R.
Ansari,
R.
Govindan,
S.
Bhatia,
D.
Bruetman,
W.
Fisher,
G.
Masters,
Angela
White,
D.
Stover,
Menggang
Yu,
N.
Hanna
(2009)
Pemetrexed in Second Line and beyond Small Cell Lung Cancer: A Hoosier Oncology Group Phase II Study
Journal of Thoracic Oncology, 4
-
A.
Davies,
W.
Evans,
J.
Mackay,
F.
Shepherd
(2004)
Treatment of recurrent small cell lung cancer.
Hematology/oncology clinics of North America, 18 2
-
A.
Inoue,
S.
Sugawara,
K.
Yamazaki,
M.
Maemondo,
Toshiro
Suzuki,
K.
Gomi,
S.
Takanashi,
C.
Inoue,
M.
Inage,
H.
Yokouchi,
H.
Watanabe,
T.
Tsukamoto,
Y.
Saijo,
O.
Ishimoto,
F.
Hommura,
T.
Nukiwa
(2008)
Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 33
-
D.
Fennell,
J.
Steele,
J.
Shamash,
S.
Slater,
M.
Sheaff,
P.
Wells,
R.
Rudd,
J.
Stebbing
(2007)
Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancer
International Journal of Cancer, 121
-
(2009)
DNA Topoisomerases
-
(2011)
Amrubicin for second-line treatment of SCLC Clinical Medicine Insights
-
T.
Yanaihara,
M.
Yokoba,
Sayaka
Onoda,
Michiko
Yamamoto,
S.
Ryuge,
Shintaro
Hagiri,
M.
Katagiri,
Mayuko
Wada,
H.
Mitsufuji,
M.
Kubota,
S.
Arai,
Hirosuke
Kobayashi,
N.
Yanase,
Tadashi
Abe,
N.
Masuda
(2007)
Phase I and pharmacologic study of irinotecan and amrubicin in advanced non-small cell lung cancer
Cancer Chemotherapy and Pharmacology, 59
-
S.
Wolff,
R.
Birch,
P.
Sarma,
F.
Greco
(1986)
Randomized dose-response evaluation of etoposide in small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial.
Cancer treatment reports, 70 5
-
K.
Furuse,
K.
Kubota,
M.
Kawahara,
M.
Takada,
I.
Kimura,
M.
Fujii,
M.
Ohta,
K.
Hasegawa,
Kiyokazu
Yoshida,
S.
Nakajima,
T.
Ogura,
H.
Niitani
(1996)
Phase II Study of Vinorelbine in Heavily Previously Treated Small Cell Lung Cancer
Oncology, 53
-
Katsuhiro
Inoue,
M.
Ogawa,
N.
Horikoshi,
T.
Mukaiyama,
Y.
Itoh,
K.
Imajoh,
H.
Ozeki,
D.
Nagamine,
K.
Shinagawa
(1989)
Phase I and pharmacokinetic study of SM-5887, a new anthracycline derivative
Investigational New Drugs, 7
-
N.
Takigawa,
T.
Ohnoshi,
H.
Ueoka,
K.
Kiura,
I.
Kimura
(1992)
Comparison of antitumor activity of new anthracycline analogues, ME2303, KRN8602, and SM5887 using human lung cancer cell lines.
Acta medica Okayama, 46 4
-
P.
D'Arpa,
Leroy-Fong
Liu
(1989)
Topoisomerase-targeting antitumor drugs.
Biochimica et biophysica acta, 989 2
-
M.
Kuffel,
J.
Reid,
M.
Ames
(2004)
Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture
Cancer Chemotherapy and Pharmacology, 30
-
Koichi
Goto,
I.
Sekine,
Y.
Nishiwaki,
R.
Kakinuma,
K.
Kubota,
Taketoshi
Matsumoto,
H.
Ohmatsu,
S.
Niho,
T.
Kodama,
T.
Shinkai,
T.
Tamura,
Y.
Ohe,
H.
Kunitoh,
N.
Yamamoto,
H.
Nokihara,
K.
Yoshida,
T.
Sugiura,
K.
Matsui,
N.
Saijo
(2004)
Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer
British Journal of Cancer, 91
-
R.
Bertrand,
Patrick
O'Connor,
D.
Kerrigan,
Y.
Pommier
(1992)
Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human colon carcinoma HT-29 cells.
European journal of cancer, 28A 4-5
-
I.
Okamoto,
A.
Hamada,
Y.
Matsunaga,
J.
Sasaki,
S.
Fujii,
H.
Uramoto,
H.
Yamagata,
I.
Mori,
H.
Kishi,
H.
Semba,
H.
Saito
(2006)
Phase I and pharmacokinetic study of amrubicin, a synthetic 9-aminoanthracycline, in patients with refractory or relapsed lung cancer
Cancer Chemotherapy and Pharmacology, 57
-
T.
Kato,
H.
Nokihara,
Y.
Ohe,
N.
Yamamoto,
I.
Sekine,
H.
Kunitoh,
K.
Kubota,
Y.
Nishiwaki,
N.
Saijo,
T.
Tamura
(2006)
Phase II trial of amrubicin in patients with previously treated small cell lung cancer (SCLC).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 18_suppl
-
K.
Furuse,
K.
Kubota,
M.
Kawahara,
M.
Takada,
I.
Kimura,
M.
Fujii,
M.
Ohta,
K.
Hasegawa,
K.
Yoshida,
S.
Nakajima,
T.
Ogura,
H.
Niitani
(1996)
Phase II study of vinorelbine in heavily previously treated small cell lung cancer. Japan Lung Cancer Vinorelbine Study Group.
Oncology, 53 2
-
Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.
-
T.
Kimura
(2001)
In vitro schedule dependency in the treatment of topoisomerase I and II inhibitor.
Osaka city medical journal, 47 1
-
G.
Sonpavde,
R.
Ansari,
P.
Walker,
D.
Sciortino,
G.
Gabryś,
A.
Murdock,
R.
Gonin,
L.
Einhorn
(2000)
Phase II study of doxorubicin and paclitaxel as second-line chemotherapy of small-cell lung cancer: a Hoosier Oncology Group Trial.
American journal of clinical oncology, 23 1
-
G.
Giaccone,
M.
Donadio,
Gianmaria
Bonardi,
F.
Testore,
A.
Calciati
(1988)
Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 6 8
-
C.
Kosmas,
N.
Tsavaris,
N.
Malamos,
M.
Vadiaka,
C.
Koufos
(2001)
Phase II study of paclitaxel, ifosfamide, and cisplatin as second-line treatment in relapsed small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 19 1
-
N.
Yoshimura,
S.
Kudoh,
Tatsuo
Kimura,
S.
Mitsuoka,
T.
Yana,
K.
Hirata
(2008)
Phase I study of amrubicin and cisplatin in previously untreated patients with advanced non-small-cell lung cancer
Journal of Clinical Oncology, 26
-
P.
Postmus,
E.
Smit
(2001)
Treatment of relapsed small cell lung cancer.
Seminars in oncology, 28 2 Suppl 4
-
M.
Fukuda,
Yoichi
Nakamura,
T.
Kasai,
S.
Nagashima,
K.
Nakatomi,
S.
Doi,
H.
Nakano,
H.
Takatani,
M.
Fukuda,
A.
Kinoshita,
H.
Soda,
K.
Tsukamoto,
M.
Oka,
S.
Kohno
(2009)
A Phase I Study of Amrubicin and Carboplatin for Previously Untreated Patients with Extensive-Disease Small Cell Lung Cancer
Journal of Thoracic Oncology, 4
-
I.
Lee,
E.
Smit,
J.
Putten,
H.
Groen,
N.
Schlösser,
P.
Postmus,
Fmnh
Schramel
(2001)
Single-agent gemcitabine in patients with resistant small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology, 12 4
-
Tomohiro
Noda,
Tomoyuki
Watanabe,
A.
Kohda,
S.
Hosokawa,
Tadashi
Suzuki
(2004)
Chronic effects of a novel synthetic anthracycline derivative (SM-5887) on normal heart and doxorubicin-induced cardiomyopathy in beagle dogs
Investigational New Drugs, 16
-
A.
Inoue,
K.
Yamazaki,
M.
Maemondo,
Takuji
Suzuki,
Y.
Kimura,
M.
Kanbe,
H.
Isobe,
M.
Nishimura,
Y.
Saijo,
T.
Nukiwa
(2006)
A Phase I Study of Amrubicin Combined with Carboplatin for Elderly Patients with Small-Cell Lung Cancer
Journal of Thoracic Oncology, 1
-
Tatsuo
Kimura,
S.
Kudoh,
S.
Mitsuoka,
N.
Yoshimura,
Hidenori
Tanaka,
K.
Asai,
S.
Kyoh,
Y.
Tochino,
K.
Umekawa,
K.
Hirata
(2009)
Plasma concentration of amrubicinol in plateau phase in patients treated for 3 days with amrubicin is correlated with hematological toxicities
Anti-Cancer Drugs, 20
-
S.
Igawa,
S.
Ryuge,
T.
Fukui,
S.
Otani,
Yuka
Kimura,
K.
Katono,
A.
Takakura,
M.
Kubota,
H.
Mitsufuji,
M.
Katagiri,
N.
Yanase,
N.
Masuda
(2010)
Amrubicin for treating elderly and poor-risk patients with small-cell lung cancer
International Journal of Clinical Oncology, 15
-
T.
Takagi,
Y.
Yazawa,
Kenichi
Suzuki,
Y.
Yamauchi,
Y.
Kano
(2004)
Effects of 13-hydroxy SM5887 in combination with other anticancer agents on human tumor cell lines
Investigational New Drugs, 14
-
G.
Batist,
D.
Carney,
K.
Cowan,
S.
Veach,
M.
Gilliom,
P.
Bunn,
D.
Ihde
(1986)
Etoposide (VP-16) and cisplatin in previously treated small-cell lung cancer: clinical trial and in vitro correlates.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 4 6